Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Clinical Trial

In a 1st, trial finds vitamin D supplements may slow multiple sclerosis. But questions remain.

A new clinical trial has shown for the first time that taking high doses of vitamin D could stave off the progression of multiple sclerosis. However, much more research is warranted to confirm these findings.

LiveScience

Scientists develop yearly HIV injection: How it could help millions

HIV prevention has leaped forward with the development of a yearly injection that may offer long-term protection against the virus. A recent clinical trial has demonstrated promising results, suggesting that this long-acting injectable medication could serve as an effective alternative to daily oral PrEP (Pre-Exposure Prophylaxis). Scientists and medical experts…

The Times of India

DOGE reportedly fired the FDA employees who were reviewing clinical trials for Elon Musk’s Neuralink

The FDA approved human clinical trials for Neuralink’s brain implants in May 2023.

Fortune

From analysis to the latest developments in health,
read the most diverse news in one place.

Groundbreaking trial discovers Ozempic could be used to tackle alcoholism epidemic

A groundbreaking clinical trial has revealed that weight-loss injections marketed as Ozempic and Wegovy may significantly reduce alcohol cravings and heavy drinking.

The Independent UK

Clinical cancer trials are vital for scientific progress – but there are many unanswered questions for patients

Australian regulators can do more to ensure measures such as age, ethnic diversity and quality of life are studied

The Guardian - AU

Personalized vaccine offers hope for patients with late-stage kidney cancer, clinical trial shows

Researchers, in a sense, manipulated each patient’s cancer in an attempt to prevent it from coming back.

Fortune

IIT Guwahati develops multi-stage clinical trial method for personalised medical care

This cutting-edge approach customises treatment regimens in real time based on each patient's individual responses during trials, resulting in highly customised and effective healthcare solutions. Read further on Dynamite News:

Dynamite News

Read news from The Economist, FT, and more,
with one subscription

Uganda starts clinical trial to combat Sudan strain of Ebola

Uganda initiates Ebola trial after a nurse’s death from the virus.

Al Jazeera

Uganda Begins Clinical Trial Of Ebola Vaccine

Uganda launches clinical trial for Ebola vaccine targeting Sudan strain after recent outbreak. Ongoing challenges in East Africa highlight importance of gl...

Top News

Delcath Systems - Super Growth Projections

Summary Delcath Systems (DCTH) shows strong technical buy signals, with a 53.41% gain since 1/25 and a 271.33% gain in the last year. The company focuses on liver cancer treatments, with its leading product HEPZATO KIT and ongoing FOCUS clinical trial for metastatic uveal melanoma. Barchart indicators highlight 100% technical...

Barchart

Get all your
news in one place.

100's of premium titles.
One news app.

Barchart

This Biotech Penny Stock Is Up 120% This Year. Analysts Think It Can Still Triple From Here in 2025.

With positive results from a clinical trial targeting Type 1 diabetes, Wall Street is feeling hot on this little biotech stock.

Fortune

No norovirus vaccine exists—yet. Moderna says it’s ‘one step closer,’ and you may be eligible to participate in its ongoing clinical trial

Up to 21 million people contract norovirus each year in the U.S. alone, the CDC says.

The National (Scotland)

Scottish university's prostate cancer imaging shows ‘extremely encouraging’ results

PROSTATE cancer imaging developed by university researchers has shown “extremely encouraging” results in its first clinical trials...

Fortune

Breast cancer drug Lynparza reduces risk of death by 28% in patients diagnosed early, clinical trial shows

About 87.5% of patients treated with the drug were alive after six years, compared to 83.2% who received a placebo.

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

Scottish patient becomes Europe’s first to receive jab for gastro-oesophageal cancer

The vaccine works by harnessing a patient’s own immune system to attack and destroy cancer.

Fortune

Is Zepbound or Wegovy better for weight loss? New clinical trial reveals which medication sheds more pounds

Amid the war on obesity, a clear winner has emerged in a battle between two weight-loss injectables.

Benzinga

Cannabinoid Drug For Agitation In Alzheimer's Yields Cognitive Improvements In Clinical Trial

IGC Pharma, Inc.(NYSE:IGC) reported additional interim data from its ongoing Phase 2 clinical trial evaluating IGC-AD1 for agitation in dementia associated with Alzheimer's disease. IGC-AD1 targets neuro-inflammation and CB1 receptor dysfunction,. The investigational drug contains THC as one of two active pharmaceutical agents.

The Conversation

RNA editing is the next frontier in gene therapy – here’s what you need to know

The United States Food and Drug Administration has just approved the first-ever clinical trial that uses CRISPR-Cas13 RNA editing. Its aim is to treat an eye disease called wet age-related macular degeneration that causes vision loss in millions of older people worldwide.

Evening Standard

Radical new cancer treatment shrinks man's deadly brain tumour by half

London hospital is leading a new clinical trial to treat glioblastoma

The Guardian - UK

Tens of thousands of UK dementia patients to be enrolled in clinical trials

News of the £20m scheme comes as new drug for Alzheimer’s was rejected for use on NHS in England

The Independent UK

£20m initiative to tackle ‘historically low’ numbers in dementia clinical trials

The Dementia Trials Accelerator will allow ‘tens of thousands’ to take part in trials.

1 … 4 5 6 7

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.